Project description
A life-changing solution for chronic fatigue syndrome patients
Chronic fatigue syndrome (CFS) is a serious and complex disorder affecting a great percentage of the global population. Often, its trigger is an infection causing a gut microflora imbalance. Despite its common cause, CFS remains frequently undiagnosed. On the other hand, when diagnosed, it is not treated effectively due to a lack of measures. The EU-funded Help4ME project aims to fill in this gap in research. The project is introducing an innovative probiotic effective in correcting gut microflora imbalances. Based on the unique combination of five lactobacilli strains with evidence-based efficacy, this novel product promises to significantly improve CFS sufferers’ quality of life.
Objective
Let’s imagine being tired to the point where any activity causes weeks of weakness and pain. Common noises and daylight become an unbearable torture and a “brain fog” doesn’t let you think clearly. In spite of the tiredness, you wake up without being refreshed, if you can fall asleep at all. Days pass as well as doctors check-ups, and no one is able to tell you what is wrong. Finally, after few years of trying to pull yourself up, the answer is Chronic Fatigue Syndrome (CFS). Happy of the fact of being diagnosed, you quickly learn that it means that there are no measures able to cure you and chances of full recovery are only 5%.
Indeed, the reality of CFS patients’ life is tough and contrary to many beliefs it is not a rare disease. The world count of diagnosed CFS is estimated for up to 24 million cases and considered to be only 10% of the whole CFS population. Although frequently triggered by infection, cause of CFS is not yet known. Researches look for its source in the guts, which are inhabited by billions of microorganisms and form a complex ecosystem with profound impact on the whole body. Imbalance of gut microflora, damaged gut barrier functions and dysfunctional immune responses are known in CFS and shared with another disease - Irritable Bowel Syndrome (IBS), which frequently accompany CFS.
GutMagnific™ is an evidence-based probiotic scientifically designed and shown to be effective in correcting the gut microflora disbalance – a source of CFS and IBS symptoms. The novelty of the product lies in the unique combination of 5 lactobacilli strains with evidence-based efficacy and shows a life-changing promise to severely underserved population of CFS patients.
Fields of science
Programme(s)
Funding Scheme
SME-1 - SME instrument phase 1Coordinator
226 50 LUND
Sweden
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.